Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Novartis AG (NVS) has a Wall Street consensus price target of $127.00, based on estimates from 25 covering analysts. With the stock currently trading at $168.62, this represents a potential downside of -24.7%. The company has a market capitalization of $321.75B.
Analyst price targets range from a low of $112.00 to a high of $143.00, representing a 24% spread in expectations. The median target of $126.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 5 analysts rating the stock as a Buy or Strong Buy,18 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, NVS trades at a trailing P/E of 23.5x and forward P/E of 19.0x. The forward PEG ratio of 1.24 indicates reasonable valuation for growth. Analysts expect EPS to grow +22.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $192.66, with bear and bull scenarios of $140.95 and $361.81 respectively. Model confidence stands at 58/100, reflecting moderate uncertainty in projections.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how NVS stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonNVS's consensus price target is $127, -24.7% below the current price of $168.62. The 25 analysts tracking NVS see downside risk at present valuations.
NVS has a consensus rating of "Hold" based on 25 Wall Street analysts. The rating breakdown is mixed, with 18 Hold ratings making up the largest segment. The consensus 12-month price target of $127 implies -24.7% downside from current levels.
With a forward P/E of 18.993x, NVS trades at a relatively low valuation. The consensus target of $127 implies -24.7% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $143 for NVS, while the most conservative target is $112. The consensus of $127 represents the median expectation. Our quantitative valuation model projects a bull case target of $362 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
NVS is heavily covered by Wall Street, with 25 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 18 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month NVS stock forecast based on 25 Wall Street analysts shows a consensus price target of $127, with estimates ranging from $112 (bear case) to $143 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $193, with bear/bull scenarios of $141/$362.
Our quantitative valuation model calculates NVS's fair value at $193 (base case), with a bear case of $141 and bull case of $362. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 58/100.
NVS trades at a forward P/E ratio of 19.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 23.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on NVS, with 2 Sell ratings and a price target of $127 (-24.7% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
NVS analyst price targets range from $112 to $143, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $127 consensus represents the middle ground. Our model's $141-$362 range provides an independent fundamental perspective.